* According to a database run by Informa Pharma Intelligence, 124 clinical trials had either been started as of Feb. 19 or were slated to begin in the coming weeks. All but three are in China.
* 40,000-plus patients are being targeted
* Nearly half of the 124 trials will test antiviral medications, and another 47 will look at whether natural products, or Chinese medicine that isn’t classified as pharmacological products, can treat the new virus